| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |